LINDA UCHE: Open Payments
NPI 1487057170 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 81 payments from 9 companies in 2025. Trend: 2023 $27 · 2024 $103 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $353 |
| Eisai Inc. | 15 | $302 |
| Alexion Pharmaceuticals, Inc. | 6 | $261 |
| ARGENX US, INC. | 20 | $260 |
| Genentech USA, Inc. | 7 | $190 |
| Lilly USA, LLC | 7 | $142 |
| SK Life Science, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $15 |
Products named: Leqembi, ULTOMIRIS, AUSTEDO XR, Ocrevus Zunovo, VYVGART HYTRULO, KISUNLA, VYVGART, AJOVY.
Industry payments across VA — which companies pay providers there.
